University of Cambridge > Talks.cam > Cambridge Oncology Seminar Series > Pathway Analysis of Glioblastoma Tissue After Preoperative Treatment with the EGFR Tyrosine Kinase Inhibitor Gefitinib – A Phase “0 Trial”

  Browse A-Z

Log in

Cambridge users (raven)details Other usersdetails No account?details

Information on

Subscribing to talksdetails Finding a talkdetails Adding a talkdetails Disseminating talksdetails Help and Documentationdetails

Pathway Analysis of Glioblastoma Tissue After Preoperative Treatment with the EGFR Tyrosine Kinase Inhibitor Gefitinib – A Phase “0 Trial”

Add to your list(s) Download to your calendar using vCal

  • UserDr Monika Hegi, University Hospital (CHUV), Lausanne, Switzerland
  • ClockTuesday 21 September 2010, 12:00-13:00
  • HouseCRI Lecture Theatre.

If you have a question about this talk, please contact Mala Jayasundera.

Abstract not available

This talk is part of the Cambridge Oncology Seminar Series series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.

Other lists

ArcDigital and CoDE talks at Anglia Ruskin Centre for Commonwealth Education (CCE) Biophysics Colloquia - (Chemistry)

Other talks

Panel Discussion: Climate Change Is Now Adaptive auditory cortical coding of speech Bioengineering conference: Innovation through convergence Building cortical networks: from molecules to function Cambridge-Lausanne Workshop 2018 - Day 2 Active bacterial suspensions: from individual effort to team work Molecular mechanisms of cardiomyopathies in patients with severe non-ischemic heart failure The Global Warming Sceptic Understanding mechanisms and targets of malaria immunity to advance vaccine development Future directions panel
 

© 2006-2024 Talks.cam, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity